MediFind

Find a Doctor

Hirokazu Nagai

National Hospital Organization Nagoya Medical Center

Bio


Hirokazu Nagai is in Nagoya, Japan. They have been an author on 134 peer reviewed articles in the past 15 years. Dr. Nagai's top three areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Hodgkin Lymphoma.

Contact

Nagoya, JP

Latest Research


Latest Advance
Study
  • Condition: Newly Diagnosed Intravascular Large B-cell Lymphoma
  • Journal: The Lancet. Oncology
  • Treatment Used: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone Combined with High-dose Methotrexate plus Intrathecal Chemotherapy
  • Number of Patients: 37
  • Published —
The study aimed to understand the safety and activity of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) with high-dose methotrexate and intrathecal chemotherapy for patients with previously untreated intravascular large B-cell lymphoma.
Latest Advance
Study
  • Condition: Follicular lymphoma
  • Journal: The Lancet. Haematology
  • Treatment Used: R-CHOP
  • Number of Patients: 300
  • Published —
This study assessed progression-free survival, overall survival, incidence of secondary malignancies, and incidence of histological transformation in patients with advanced follicular lymphoma 10-years following R-CHOP chemotherapy.
Latest Advance
Study
  • Condition: Peripheral T cell lymphoma
  • Journal: Annals of hematology
  • Treatment Used: Forodesine
  • Number of Patients: 48
  • Published —
This study evaluated the efficacy and safety of forodesine in patients with relapsed peripheral T cell lymphoma.
Latest Advance
Study
  • Condition: Mantle cell lymphoma
  • Journal: Cancer science
  • Treatment Used: R-High-CHOP/CHASER/LEED with autologous stem cell transplantation
  • Number of Patients: 45
  • Published —
This study evaluated the effects of immunochemotherapy of R-High-ChOP/CHASER followed by HDC of LEED with ASCT in young patients with untreated mantle cell lymphoma.

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

Nagoya, JP

Insurance

Contact them to find out if they accept your insurance plan.